A pill for some anemias?

Blood

Volumn 110, Issue 6, 2007, Pages 1709-

  Persons, Derek A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; ERYTHROPOIETIN; FG 2216; HEMOGLOBIN F; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROLYL HYDROXYLASE INHIBITOR; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ANGIOGENESIS; CANCER; CARCINOGENESIS; ERYTHROPOIESIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYDROXYLATION; KIDNEY FAILURE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RHESUS MONKEY; TREATMENT DURATION;

EID: 34548847163     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-06-096719     Document Type: Note

References (3)

1. Jelkmann W. Erythropoietin after a century of research: younger than ever. Eur J Haematol. 2007;78:183-205.
2. Bunn HF. New agents that stimulate erythropoiesis. Blood. 2007;109:868-873.
3. Metzen E, Ratcliffe PJ. HIF hydroxylation and cellular oxygen sensing. Biol Chem. 2004;385:223-230.